ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
1679	National Cancer Institute	Html	en	Communication in Cancer Care (PDQ®)–Patient Version	It is important to talk to your doctor about your cancer diagnosis, goals of treatment, plan of care, and what to expect over time. Learn how good communication between patients, families, caregivers and doctors can improve the patient's quality of life in this expert-reviewed summary.	cancer treatment 0.389842 bad news 0.386292 questions 0.399361 PDQ cancer information 0.624305 health care team 0.981737 clinical trials 0.514782 Pediatric Supportive Care 0.404638 communication 0.486074 cancer information summary 0.515585 clinical trial 0.495706 family members 0.426143 cancer care 0.778281 breast cancer prevention 0.399685 PDQ summaries 0.394467 patients 0.573309 cancer patients 0.414288 team share information 0.427277 latest published information 0.403211 NCI’s PDQ 0.394236 PDQ summary Family 0.458483 NCI PDQ cancer 0.456705 supportive care 0.443184 treatment 0.599848 family caregivers 0.667411	cancer prevention 0.402033 Cancer Information Service 0.427003 Explain medical information 0.409499 PDQ Supportive 0.391221 patient 0.679815 PDQ Communication 0.403164 treatment clinical trials 0.401111 National Cancer Institute 0.597923 decisions 0.454448 PDQ documents 0.390179 Palliative Care Editorial 0.462952 medical information 0.462988 new treatment 0.398754 good communication 0.425774 Cancer Care page 0.429643 PDQ database 0.392979 Care Editorial Board 0.465833 PDQ summary 0.483184 doctor 0.450453 cancer clinical trials 0.415988 cancer information summaries 0.432334 comprehensive cancer information 0.43347 cancer patient 0.392432 cancer 0.840307	CLICK HERE
1760	National Cancer Institute	Html	en	Obesity and Cancer	A fact sheet that summarizes the evidence linking overweight and obesity to the risk of various cancers and to cancer survivorship.	obesity causes cancer 0.394065 normal-weight people 0.279732 observational studies 0.323456 obesity prevalence 0.293137 obesity 0.638496 thyroid cancer risk 0.290632 obese people 0.350767 risk factors 0.298103 multiple myeloma 0.271306 colorectal cancer 0.326707 ovarian cancer 0.293192 body mass index 0.723663 prostate cancer risk 0.293391 postmenopausal breast cancer 0.29585 weight loss 0.380764 endometrial cancer increases 0.279353 cancer incidence data 0.260252 different cancer risk 0.325913 breast cancer survivors 0.303032 kidney cancer 0.323356 endometrial cancer 0.299756 invasive breast cancer 0.260923 menopausal hormone therapy 0.326286 women 0.298824 gallbladder cancer 0.347557	United States 0.307003 weight gain 0.259995 male breast cancer 0.288797 breast cancer diagnosis 0.278716 pancreatic cancer 0.309076 different cancer types 0.265661 LeRoith D. Obesity 0.262512 National Cancer Institute 0.329185 extremely obese women 0.271426 renal cell cancer 0.355343 increase cancer risk 0.312393 breast cancer risk 0.439989 breast cancer 0.64758 C. Gallbladder cancer 0.256715 cancer survivorship 0.270564 prostate cancer 0.294021 Breast Cancer WEight 0.309447 pancreatic cancer risk 0.295039 breast cancer pooling 0.266031 prospective studies 0.320099 et al 0.828361 cancer risk 0.662021 cancer 0.97959 liver cancer 0.398322	CLICK HERE
1816	National Cancer Institute	Html	es	Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil.	gliomas highlights platelet-derived 0.0180248 encefálico infantiles recién 0.0174306 focal brainstem gliomas 0.0175295 brainstem tumors 0.0356739 mutación h3 k27m 0.0183362 activating acvr1 mutations 0.0269847 pediatric brain 0.0219051 glioma with 0.0184685 encefálico focales recidivantes 0.0176848 Radiat Oncol Biol 0.0940294 Pediatric Brain Tumor 0.0189297 mutación h3 0.0289221 diffuse brainstem glioma 0.0359565 brainstem gliomas 0.119063 central nervous system 0.0139993 recurrent activating acvr1 0.0274852 Nat Genet 0.0675122 intrinsic brain stem 0.0150908 patients with 0.025125 radiation therapy 0.0349088 intrinsic pontine glioma 0.946885 Acta Neuropathol 0.0426011 encefálico infantiles grupo 0.0167365 Broniscer A 0.0151338 intrinsic brainstem gliomas 0.0346829	Pediatric MATCH 0.0156687 encefálico focales recién 0.0279293 Neuro Oncol 0.0299682 with newly 0.0211799 brain stem gliomas 0.0552126 encefálico infantiles recidivantes 0.0293915 pediatric patients 0.0205505 low-grade glioma 0.0256326 Pediatr Blood Cancer 0.019874 intracranial low-grade gliomas 0.0165924 report from 0.0151672 tumores dipg 0.0243332 encefálico focales resección 0.0182395 Clin Oncol 0.0362551 Oncol Biol Phys 0.0989347 Zhou T 0.0230102 Neurosurg Pediatr 0.0180743 Pediatric Oncology Group 0.0173483 newly diagnosed 0.0303637 with neurofibromatosis 0.0165895 children's oncology group 0.138637 Acta Neuropathol Commun 0.0194776 Childs Nerv Syst 0.0434615 diffuse intrinsic pontine 0.990784	CLICK HERE
1921	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	almacena agua 0.377251 siguientes procedimientos 0.484494 Estadio IA 0.400496 estadio iv 0.835623 Estadio IC 0.400325 siguientes aspectos 0.39369 estadio ii 0.685519 Estadio IIIC 0.402008 estadios ia 0.349569 Estadio IIIA 0.403211 rayos x 0.363326 pulmón.ampliar cáncer 0.632928 menor cantidad 0.423989 luz solar 0.966967 Basal Cell Carcinoma 0.789488 vitamina d 0.373991 National Cancer Institute 0.332744	vitamina a 0.337818 siguientes riesgos 0.326866 pequeños carcinomas 0.336448 Instituto Nacional 0.361575 PDQ Tratamiento 0.358407 Drugs Approved 0.513635 Physician Data Query 0.424982 Cabello pelirrojo 0.519578 lápiz mide 0.408824 siguientes características 0.456672 cara.ampliar cirugía 0.345299 aspecto anormal.ampliar biopsia 0.448697 piel causa efectos 0.518422 panel derecho 0.432885 siguientes sumarios 0.432177 siguientes pruebas 0.387403	CLICK HERE
1923	National Cancer Institute	Html	es	Tratamiento del melanoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del melanoma.	almacena agua 0.234953 siguientes procedimientos 0.33648 estadio iv 0.436307 siguientes aspectos 0.242705 CTLA-4.Ampliar Inhibidor 0.229258 genes braf 0.219515 pequeña cantidad 0.22974 siguientes tipos 0.26039 estadios ia 0.227409 ganglio linfático centinela 0.971469 rayos x 0.230817 estadio ib 0.421722 estadio ia 0.418874 enlace drugs approved 0.315654 células t 0.340582 luz solar 0.830082 PD-1.Ampliar Inhibidor 0.228522 vitamina d 0.235166	National Cancer Institute 0.217987 lunar atípico 0.239383 Instituto Nacional 0.232974 estadios iia 0.230643 PDQ Tratamiento 0.658062 melanoma causa efectos 0.315066 antecedentes familiares 0.293778 cabo pruebas 0.278327 estadio iia 0.421244 estadio iic 0.418402 PDQ Exámenes 0.269726 Physician Data Query 0.266129 lápiz mide 0.244567 estadio iii 0.594614 siguientes situaciones 0.233677 panel derecho 0.258009 siguientes pruebas 0.238893 melanoma ocular uveal 0.435674	CLICK HERE
1929	National Cancer Institute	Html	es	Tratamiento del carcinoma de sitio primario desconocido (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer metastásico que se diseminó desde un sitio primario desconocido.	PDQ Tratamiento 0.503744 siguientes procedimientos 0.523984 alta potencia 0.503524 siguientes elementos 0.505673 siguientes aspectos 0.504431 Physician Data Query 0.507109 coriónica humana beta 0.506354 radioterapia externa causa 0.507986 tumor primario oculto.Ampliar 0.520296 siguientes razones 0.505928 siguientes tipos 0.504856	vía oral 0.502538 rayos x 0.503516 sitio primario desconocido 0.964151 Sudores nocturnos 0.504661 cuáles pruebas 0.503677 numerosos ensayos 0.506292 National Cancer Institute 0.501623 siguientes riesgos 0.501356 células cancerosas ayuda 0.516934 Instituto Nacional 0.503286	CLICK HERE
1980	National Cancer Institute	Html	es	Tratamiento del sarcoma de Ewing (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de la familia del sarcoma de Ewing.	Cirujano oncólogo 0.631512 siguientes procedimientos 0.653106 células madre 0.978655 adultos jóvenes 0.637237 faja ajustadora 0.638641 vía oral 0.627826 rayos x 0.63487 estudio tipos 0.620537 enlace drugs approved 0.646857 niño ayuda 0.64117 células t 0.686984 efectos tardíos 0.851996 PDQ Efectos tardíos 0.679663 Ewing extraóseo 0.77445 National Cancer Institute 0.625093 IRMN).Ampliar Imágenes 0.631059	encontrarlo.ampliar exploración 0.638439 ortopedista oncólogo 0.633744 Instituto Nacional 0.644246 PDQ Tratamiento 0.658351 determinados cambios 0.617816 Ewing causa efectos 0.748473 presente sección 0.621848 explorador tep 0.641296 nuevos tipos 0.626452 Physician Data Query 0.690644 Soft Tissue Sarcoma 0.727359 diseminó.ampliar aspiración 0.638694 quimioterapia sistémica forma 0.678849 leucemia mieloide aguda 0.649605 tumor óseo 0.67804 siguientes pruebas 0.708113	CLICK HERE
2075	National Cancer Institute	Html	es	Cánceres de cabeza y cuello	Hoja informativa acerca de los factores de riesgo, síntomas, diagnóstico, tratamiento, seguimiento y rehabilitación por los cánceres de cabeza y cuello.	Neck Cancer Epidemiology 0.358567 3rd ed 0.326841 NCI Vacunas 0.308043 American Cancer Society 0.337456 Epstein-Barr virus with 0.308914 Epstein-Barr virus 0.318034 Cancer Statistics 0.318768 Winn DM 0.308575 escamoso metastático 0.312489 case-control studies 0.308924 Cancer Institute State 0.321996 risk factors 0.312336 Brennan P 0.309874 Estados Unidos 0.32769 PubMed Abstract 0.972002 Gillison ML 0.308728 neck cancers 0.463711 Leclerc A 0.308319 patients with 0.31588 Cancer Epidemiology 0.478301 epstein-barr virus dna 0.30801 Boffetta P 0.327923 Chuang SC 0.308139 Cancer Epidemiology Consortium 0.352034 Cancer Journal 0.322016	International Journal 0.329442 Schottenfeld D 0.32536 upper aerodigestive tract 0.317554 second primary tumors 0.315336 United States 0.307873 neck squamous 0.307836 Fraumeni JF Jr 0.348613 International Head 0.313722 Nasopharyngeal Cancer 0.321339 occupational exposure 0.308922 National Cancer Institute 0.392376 Cancer Research 0.332513 Oxford University 0.322621 New York 0.321319 Yuan JM 0.308767 Epstein-Barr virus infection 0.308137 nasopharyngeal carcinoma 0.309899 international case-control study 0.316625 cáncer del nci 0.316951 Neck Surgery 0.30769 pooled analysis 0.329801 Clinical Cancer Research 0.320259 Habitual risk factors 0.308377 Cancer Biology 0.320747	CLICK HERE
3450	National Cancer Institute	Html	en	Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version	Expert-reviewed information summary about the preparation needed by health care providers, patients, and families for the transition to end-of-life care in advanced cancer.	lung cancer 0.641373 Cancer patient preferences 0.503664 American Cancer Society 0.471339 palliative care cohort 0.487911 health care providers 0.49452 advance care planning 0.617548 Cancer Care Outcomes 0.545737 Care Outcomes Research 0.519676 colorectal cancer 0.485035 ill hospitalized patients 0.478763 incurable cancer patients 0.49288 breast cancer patients 0.489402 patients 0.763742 cancer patients 0.59867 elderly cancer patients 0.49242 EOL health care 0.473964 incurable cancer 0.495495 decision making 0.513832 metastatic breast cancer 0.474641 et al. 0.585917 care 0.714724 end-of-life care 0.494853 treatment 0.487292 palliative care interventions 0.478305 study 0.52262	Palliative care communication 0.477608 metastatic non-small-cell lung 0.492002 Palliat Support Care 0.474344 palliative care 0.683174 PUBMED Abstract 0.539791 Hosp Palliat Care 0.499255 treatment preferences 0.470843 Support Care Cancer 0.520243 advanced lung cancer 0.489792 advanced colorectal cancer 0.478138 palliative oncology care 0.483778 lung cancer patients 0.527648 early palliative care 0.566869 Intern Med 0.533629 preferences 0.530446 advanced cancer 0.753385 advance directives 0.485421 Abstract 0.690455 Clin Oncol 0.911079 Arch Intern Med 0.488878 medical care 0.489903 randomized controlled trial 0.484267 health care decisions 0.476382 cell lung cancer 0.493742	CLICK HERE